Exagen Inc.
corporate_fare Company Profile
Exagen Inc. (NASDAQ:XGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for XGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for XGN spans S-3, 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Exagen Registers $150M Shelf, Including $50M TD Securities ATM
- Exagen Registers $150M Shelf With $50M TD Cowen ATM, ~34% Dilution at $5.81
- Exagen Q3: Revenue Up 7% to $18.4M, Cash Slips to $28.1M as New $50M ATM Launches
- Exagen Posts 25-Cent Quarterly Loss as Diagnostics Firm's Results Land
- Exagen Q2 Revenue Jumps 16% on 11% Test Volume Growth, Loss Narrows Sharply
Financial Snapshot
Short Interest & Short Volume
1.98 days to coverFINRA reported short interest of 727,455 shares in XGN as of the October 30, 2026 settlement, a 8.0% increase from the prior period — about 2.0 days to cover at its recent average daily volume. On November 20, 2026, 25.8% of XGN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for XGN, detected from its recent SEC filings · based on capital-structure filings through 2026-11-17.
ATM Prospectus Filed for $50M · Share Count and Dilution Math
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →